A new treatment has been proposed for immunotherapy-resistant brain metastases, with a biomarker identified that can predict ...

Researchers at the Spanish National Cancer Research Centre (CNIO) propose a new treatment for brain metastases that respond poorly, or not at all, to immunotherapy, and provide a biomarker to predict ...

Researchers at CNIO discovered that cancer manipulates brain cells called astrocytes, causing them to produce a protein that ...

To cultivate crops like lettuce that can better withstand diseases, researchers from Delft University of Technology and ...

The FDA bestows a Fast Track designation to Ionis' investigational candidate, zilganersen, for treating a rare neurological ...

In brain metastasis, cancer has been found to alter the course of certain astrocytes and causes them to produce a protein that works in the tumor's favor.

A drug called silibinin can block this protein and, when used with immunotherapy, may improve treatment for brain metastases.

"The pharmacological and genetic modulation of astrocytic autophagy pathway can be considered for boosting the detoxifying ...

In this episode we speak with bit.bio about astrocytes and how bit.bio's innovative technology is transforming research in ...

Eight other mouse lines were also genotyped as previously described, targeting various cell types and pathways, such as microglia, astrocytes, oligodendrocyte precursor cells, and oligodendrocytes.